coumarin-3-carboxylic acid has been researched along with Carcinoma, Anaplastic in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Creaven, BS; Devereux, M; Egan, DA; Kavanagh, K; McCann, M; Noble, A; Thati, B; Walsh, M | 1 |
1 other study(ies) available for coumarin-3-carboxylic acid and Carcinoma, Anaplastic
| Article | Year |
|---|---|
In vitro anti-tumour and cyto-selective effects of coumarin-3-carboxylic acid and three of its hydroxylated derivatives, along with their silver-based complexes, using human epithelial carcinoma cell lines.
Topics: Antineoplastic Agents; Carcinoma; Cell Line, Tumor; Coumarins; DNA; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Electrophoretic Mobility Shift Assay; Humans; In Vitro Techniques; Inhibitory Concentration 50; Mutagenicity Tests; Silver Compounds | 2007 |